Engineering synthetic signaling receptors to enable erythropoietin-free erythropoiesis
Abstract Blood transfusion plays a vital role in modern medicine, but frequent shortages occur. Ex vivo manufacturing of red blood cells (RBCs) from universal donor cells offers a potential solution, yet the high cost of recombinant cytokines remains a barrier. Erythropoietin (EPO) signaling is cruc...
Saved in:
Main Authors: | Aadit P. Shah, Kiran R. Majeti, Freja K. Ekman, Sridhar Selvaraj, Devesh Sharma, Roshani Sinha, Eric Soupene, Prathamesh Chati, Sofia E. Luna, Carsten T. Charlesworth, Travis McCreary, Benjamin J. Lesch, Tammy Tran, Simon N. Chu, Matthew H. Porteus, M. Kyle Cromer |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-025-56239-5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Erythropoietin: from erythropoiesis to cardioprotection
by: Liermis Michael Dita Salabert, et al.
Published: (2010-08-01) -
Defective Slc7a7 transport reduces erythropoietin compromising erythropoiesis
by: Judith Giroud-Gerbetant, et al.
Published: (2025-01-01) -
Erythrocytes and Erythropoietin
by: Michael Föller, et al.
Published: (2011-01-01) -
Ineffective Erythropoiesis in β-Thalassemia
by: Jean-Antoine Ribeil, et al.
Published: (2013-01-01) -
Crosstalk between Erythropoiesis and Iron Metabolism
by: Stefano Rivella, et al.
Published: (2010-01-01)